Abstract
Melatonin is a hormone produced by the brain in response to low levels of light. It plays an important role in the regulation of the internal circadian clock as well as sleep/wake regulation. Children on the autism spectrum have dysregulation of the melatonin system which likely contributes to sleep problems. Administration of exogenous melatonin is commonly prescribed for children on the autism spectrum whose sleep problems are not improved with behavioral approaches. This chapter will outline the rationale for melatonin as a treatment for sleep problems in children on the autism spectrum, summarize the evidence for this approach, and provide an outline for the implementation of melatonin treatment for sleep problems in children on the autism spectrum.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amaral, F. G. D., & Cipolla-Neto, J. (2018). A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab, 62(4), 472–479. https://doi.org/10.20945/2359-3997000000066
Andersen, I. M., Kaczmarska, J., McGrew, S. G., & Malow, B. A. (2008). Melatonin for insomnia in children with autism spectrum disorders [Clinical Trial]. Journal of Child Neurology, 23(5), 482–485. https://doi.org/10.1177/0883073807309783
Baddam, S. K. R., Canapari, C. A., van Noordt, S. J. R., & Crowley, M. J. (2018). Sleep disturbances in child and adolescent mental health disorders: A review of the variability of objective sleep markers. Medical Sciences (Basel, Switzerland), 6(2), 46. https://doi.org/10.3390/medsci6020046
Braam, W., Ehrhart, F., Maas, A., Smits, M. G., & Curfs, L. (2018). Low maternal melatonin level increases autism spectrum disorder risk in children. Research in Developmental Disabilities, 28, 28. https://doi.org/10.1016/j.ridd.2018.02.017
Bruni, O., Alonso-Alconada, D., Besag, F., Biran, V., Braam, W., Cortese, S., Moavero, R., Parisi, P., Smits, M., Van der Heijden, K., & Curatolo, P. (2015). Current role of melatonin in pediatric neurology: Clinical recommendations [Review]. European Journal of Paediatric Neurology, 19(2), 122–133. https://doi.org/10.1016/j.ejpn.2014.12.007
Bruni, O., Ottaviano, S., Guidetti, V., Romoli, M., Innocenzi, M., Cortesi, F., & Giannotti, F. (1996). The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. Journal of Sleep Research, 5(4), 251–261.
Brzezinski, A., Vangel, M. G., Wurtman, R. J., Norrie, G., Zhdanova, I., Ben-Shushan, A., & Ford, I. (2005). Effects of exogenous melatonin on sleep: A meta-analysis. Sleep Medicine Reviews, 9(1), 41–50. https://doi.org/10.1016/j.smrv.2004.06.004
Cipolla-Neto, J., & do Amaral, F. G. (2018). Melatonin as a hormone: New physiological and clinical insights. Endocrine Reviews. https://doi.org/10.1210/er.2018-00084
Claustrat, B., Brun, J., & Chazot, G. (2005). The basic physiology and pathophysiology of melatonin. Sleep Medicine Reviews, 9(1), 11–24. https://doi.org/10.1016/j.smrv.2004.08.001
Cortesi, F., Giannotti, F., Sebastiani, T., Panunzi, S., & Valente, D. (2012). Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: A randomized placebo-controlled trial. Journal of Sleep Research, 21(6), 700–709. https://doi.org/10.1111/j.1365-2869.2012.01021.x
Cuomo, B. M., Vaz, S., Lee, E. A. L., Thompson, C., Rogerson, J. M., & Falkmer, T. (2017). Effectiveness of sleep-based interventions for children with autism spectrum disorder: A meta-synthesis [Meta-Analysis Review]. Pharmacotherapy: The Journal of Human Pharmacology & Drug Therapy, 37(5), 555–578. https://doi.org/10.1002/phar.1920
Diethelm, K., Libuda, L., Bolzenius, K., Griefahn, B., Buyken, A. E., & Remer, T. (2010). Longitudinal associations between endogenous melatonin production and reported sleep duration from childhood to early adulthood. Hormone Research in Pdiatrics, 74(6), 390–398. (Not in File).
Elkhayat, H. A., Hassanein, S. M., Tomoum, H. Y., Abd-Elhamid, I. A., Asaad, T., & Elwakkad, A. S. (2010). Melatonin and sleep-related problems in children with intractable epilepsy. Pediatric Neurology, 42(4), 249–254. https://doi.org/10.1016/j.pediatrneurol.2009.11.002. (Not in File).
Garstang, J., & Wallis, M. (2006). Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child: Care, Health and Development, 32(5), 585–589. https://doi.org/10.1111/j.1365-2214.2006.00616.x. (Not in File).
Gevi, F., Zolla, L., Gabriele, S., & Persico, A. M. (2016). Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism [Research Support, Non-U.S. Gov’t]. Molecular Autism, 7, 47. https://doi.org/10.1186/s13229-016-0109-5
Giannotti, F., Cortesi, F., Cerquiglini, A., & Bernabei, P. (2006). An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. Journal of Autism and Developmental Disorders, 36(6), 741–752. https://doi.org/10.1007/s10803-006-0116-z. (Not in File).
Goldberg-Stern, H., Oren, H., Peled, N., & Garty, B. Z. (2012). Effect of melatonin on seizure frequency in intractable epilepsy: A pilot study. Journal of Child Neurology, 27(12), 1524–1528. https://doi.org/10.1177/0883073811435916. (Not in File).
Goldman, S. E., Adkins, K. W., Calcutt, M. W., Carter, M. D., Goodpaster, R. L., Wang, L., Shi, Y., Burgess, H. J., Hachey, D. L., & Malow, B. A. (2014). Melatonin in children with autism spectrum disorders: Endogenous and pharmacokinetic profiles in relation to sleep [Research Support, N.I.H., Extramural]. Journal of Autism & Developmental Disorders, 44(10), 2525–2535. https://doi.org/10.1007/s10803-014-2123-9
Goldman, S. E., Alder, M. L., Burgess, H. J., Corbett, B. A., Hundley, R., Wofford, D., Fawkes, D. B., Wang, L., Laudenslager, M. L., & Malow, B. A. (2017). Characterizing sleep in adolescents and adults with autism spectrum disorders [Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Journal of Autism and Developmental Disorders, 47(6), 1682–1695. https://doi.org/10.1007/s10803-017-3089-1
Gringras, P., Nir, T., Breddy, J., Frydman-Marom, A., & Findling, R. L. (2017). Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder [Randomized Controlled Trial]. Journal of the American Academy of Child and Adolescent Psychiatry, 56(11), 948–957. https://doi.org/10.1016/j.jaac.2017.09.414
Gupta, R., & Hutchins, J. (2005). Melatonin: A panacea for desperate parents? (Hype or truth). Archives of Disease in Childhood, 90(9), 986–987. https://doi.org/10.1136/adc.2005.075218. (Not in File).
Hopf, K. P., Madren, E., & Santianni, K. A. (2016). Use and perceived effectiveness of complementary and alternative medicine to treat and manage the symptoms of autism in children: A survey of parents in a community population. Journal of Alternative & Complementary Medicine, 22(1), 25–32. https://doi.org/10.1089/acm.2015.0163
Howes, O. D., Rogdaki, M., Findon, J. L., Wichers, R. H., Charman, T., King, B. H., Loth, E., McAlonan, G. M., McCracken, J. T., Parr, J. R., Povey, C., Santosh, P., Wallace, S., Simonoff, E., & Murphy, D. G. (2018). Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. Journal of Psychopharmacology, 32(1), 3–29. https://doi.org/10.1177/0269881117741766
Katz, T., Shui, A. M., Johnson, C. R., Richdale, A. L., Reynolds, A. M., Scahill, L., & Malow, B. A. (2018). Modification of the children’s sleep habits questionnaire for children with autism spectrum disorder [journal article]. Journal of Autism and Developmental Disorders, 48(8), 2629–2641. https://doi.org/10.1007/s10803-018-3520-2
Kawabe, K., Horiuchi, F., Oka, Y., & Ueno, S. (2014). The melatonin receptor agonist ramelteon effectively treats insomnia and behavioral symptoms in autistic disorder. Case Reports Psychiatry, 2014, 561071. https://doi.org/10.1155/2014/561071
Kulman, G., Lissoni, P., Rovelli, F., Roselli, M. G., Brivio, F., & Sequeri, P. (2000). Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinology Letters, 21(1), 31–34.
Leu, R. M., Beyderman, L., Botzolakis, E. J., Surdyka, K., Wang, L., & Malow, B. A. (2011). Relation of melatonin to sleep architecture in children with autism. Journal of Autism and Developmental Disorders, 41(4), 427–433. https://doi.org/10.1007/s10803-010-1072-1. (Not in File).
Macchi, M. M., & Bruce, J. N. (2004). Human pineal physiology and functional significance of melatonin. Frontiers in Neuroendocrinology, 25(3), 177–195. https://doi.org/10.1016/j.yfrne.2004.08.001
Malow, B., Adkins, K. W., McGrew, S. G., Wang, L., Goldman, S. E., Fawkes, D., & Burnette, C. (2012). Melatonin for sleep in children with autism: A controlled trial examining dose, tolerability, and outcomes. Journal of Autism and Developmental Disorders, 42(8), 1729–1737.; author reply 1738. (Not in File). https://doi.org/10.1007/s10803-011-1418-3
Malow, B. A., Katz, T., Reynolds, A. M., Shui, A., Carno, M., Connolly, H. V., Coury, D., & Bennett, A. E. (2016). Sleep difficulties and medications in children with autism spectrum disorders: A registry study [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Pediatrics, 137(Suppl 2), S98–S104. https://doi.org/10.1542/peds.2015-2851H
Maras, A., Schroder, C. M., Malow, B. A., Findling, R. L., Breddy, J., Nir, T., Shahmoon, S., Zisapel, N., & Gringras, P. (2018). Long-term efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. Journal of Child & Adolescent Psychopharmacology, 22, 22. https://doi.org/10.1089/cap.2018.0020
Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsater, H., Rastam, M., Stahlberg, O., Gillberg, I. C., Delorme, R., Chabane, N., Mouren-Simeoni, M. C., Fauchereau, F., Durand, C. M., Chevalier, F., Drouot, X., Collet, C., Launay, J. M., Leboyer, M., … Bourgeron, T. (2008). Abnormal melatonin synthesis in autism spectrum disorders. Molecular Psychiatry, 13(1), 90–98. https://doi.org/10.1038/sj.mp.4002016. (Not in File).
Nir, I., Meir, D., Zilber, N., Knobler, H., Hadjez, J., & Lerner, Y. (1995). Brief report: Circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. Journal of Autism and Developmental Disorders, 25(6), 641–654. https://www.ncbi.nlm.nih.gov/pubmed/8720032. (Not in File)
Owens, J. A., Spirito, A., & McGuinn, M. (2000). The Children’s Sleep Habits Questionnaire (CSHQ): Psychometric properties of a survey instrument for school-aged children. Sleep, 23(8), 1043–1051. https://doi.org/10.1093/sleep/23.8.1d
Paavonen, E. J., Nieminen-von Wendt, T., Vanhala, R., Aronen, E. T., & von Wendt, L. (2003). Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder [Clinical Trial Comparative Study Research Support, Non-U.S. Gov’t]. Journal of Child & Adolescent Psychopharmacology, 13(1), 83–95. https://doi.org/10.1089/104454603321666225
Sandyk, R. (1992). Melatonin and maturation of REM sleep. The International Journal of Neuroscience, 63(1–2), 105–114. https://doi.org/10.3109/00207459208986660
Tetreault, E., Belanger, M. E., Bernier, A., & Carrier, J. (2018). Actigraphy data in pediatric research: The role of sleep diaries. Sleep Medicine, 47, 86–92. https://doi.org/10.1016/j.sleep.2017.11.1144
Tordjman, S., Anderson, G. M., Pichard, N., Charbuy, H., & Touitou, Y. (2005). Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biological Psychiatry, 57(2), 134–138. https://doi.org/10.1016/j.biopsych.2004.11.003. (Not in File).
Veatch, O. J., Goldman, S. E., Adkins, K. W., & Malow, B. A. (2015a). Melatonin in children with autism spectrum disorders: How does the evidence fit together? The Journal of Natural Science, 1(7), e125.
Veatch, O. J., Pendergast, J. S., Allen, M. J., Leu, R. M., Johnson, C. H., Elsea, S. H., & Malow, B. A. (2015b). Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay [Research Support, N.I.H., Extramural]. Journal of Autism and Developmental Disorders, 45(1), 100–110. https://doi.org/10.1007/s10803-014-2197-4
Wams, E. J., Woelders, T., Marring, I., van Rosmalen, L., Beersma, D. G. M., Gordijn, M. C. M., & Hut, R. A. (2017). Linking light exposure and subsequent sleep: A field polysomnography study in humans [Research Support, Non-U.S. Gov’t]. Sleep, 40(12), 01. https://doi.org/10.1093/sleep/zsx165
Wirojanan, J., Jacquemont, S., Diaz, R., Bacalman, S., Anders, T. F., Hagerman, R. J., & Goodlin-Jones, B. L. (2009). The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. [Erratum appears in J Clin Sleep Med. 2010 Aug 15;6(4):preceding 311]. Journal of Clinical Sleep Medicine, 5(2), 145–150. (Not in File).
Wright, B., Sims, D., Smart, S., Alwazeer, A., Alderson-Day, B., Allgar, V., Whitton, C., Tomlinson, H., Bennett, S., Jardine, J., McCaffrey, N., Leyland, C., Jakeman, C., & Miles, J. (2011). Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: A randomised controlled crossover trial [Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. Journal of Autism & Developmental Disorders, 41(2), 175–184. https://doi.org/10.1007/s10803-010-1036-5
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
MacLean, J.E., Malow, B.A. (2022). The Treatment of Sleep Problems Using Melatonin. In: McLay, L.K., France, K.G., Blampied, N.M. (eds) Clinical Handbook of Behavioral Sleep Treatment in Children on the Autism Spectrum. Springer, Cham. https://doi.org/10.1007/978-3-030-99134-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-99134-0_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-99133-3
Online ISBN: 978-3-030-99134-0
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)